1. Kim TH, Jeong SY, Choi DH et al (2008) Lateral lymph node metas- tasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 15:729–737
2. Kim MJ, Oh JH (2018) Lateral lymph node dissection with the focus on indications, functional outcomes, and minimally invasive surgery. Ann Coloproctol 34:229–233
3. Heald RJ, Ryall RD (1986) Recurrence and survival after total meso- rectal excision for rectal cancer. Lancet 1:1479–1482
4. Maurer CA, Renzulli P, Kull C et al (2011) The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results. Ann Surg Oncol 18:1899–1906
5. Kusters M, Beets GL, van de Velde CJ et al (2009) A compari- son between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 249:229–235
6. Cecconello I, Araujo SE, Seid VE et al (2011) Laparoscopic total mesorectal excision: early and late results. Asian J Endosc Surg 4:99–106
7. Fujita S, Mizusawa J, Kanemitsu Y et al (2017) Mesorectal exci- sion with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled. Noninferiority Trial Ann Surg 266:201–207
8. Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42
9. Swedish Rectal Cancer Trial, Cedermark B, Dahlberg M et al (1997) Improved survival with preoperative radiotherapy in resectable rec- tal cancer. N Engl J Med 336:980–987
10. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
11. Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:874–901
12. Matsuoka H, Nakamura A, Masaki T et al (2007) Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res 27:3529–3533
13. Akiyoshi T, Matsueda K, Hiratsuka M et al (2015) Indications for lateral pelvic lymph node dissection based on magnetic reso- nance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol 22(Suppl 3):S614–S620
14. Ogawa S, Hida J, Ike H et al (2016) Selection of lymph node-posi- tive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese society for can- cer of the colon and rectum. Ann Surg Oncol 23:1187–1194
15. Chen LD, Liang JY, Wu H et al (2018) Multiparametric radiomics improve prediction of lymph node metastasis of rectal cancer com- pared with conventional radiomics. Life Sci 208:55–63
16. Nakanishi R, Akiyoshi T, Toda S et al (2020) Radiomics approach outperforms diameter criteria for predicting pathological lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in advanced low rectal cancer. Ann Surg Oncol 27(11):4273–4283
17. Kawai K, Sunami E, Yamaguchi H et al (2015) Nomograms for colorectal cancer: a systematic review. World J Gastroenterol 21(41):11877–11886
18. Takenaka Y, Miyoshi N, Fujino S et al (2020) Development of a novel prediction model for recurrent stage II colon cancer. Surg Today 50(4):389–395
19. Zhang J, Xiao L, Pu S et al (2021) Can we reliably identify the pathological outcomes of neoadjuvant chemotherapy in patients with breast cancer? Development and validation of a logistic regres- sion nomogram based on preoperative factors. Ann Surg Oncol 28(5):2632–2645
20. Moons KG, Altman DG, Reitsma JB et al (2015) Transparent Reporting of a multivariable prediction model for Individual Prog- nosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1–W73
21. Hida K, Okamura R, Sakai Y et al (2018) Open versus laparoscopic surgery for advanced low rectal cancer: a large, multicenter, propen- sity score matched cohort study in Japan. Ann Surg 268:318–324
22. MERCURY Study Group (2006) Diagnostic accuracy of preopera- tive magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333(7572):779
23. Smith NJ, Barbachano Y, Norman AR et al (2008) Prognostic signif- icance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95:229–236
24. Sanchez-Pinto LN, Venable LR, Fahrenbach J et al (2018) Compari- son of variable selection methods for clinical predictive modeling. Int J Med Inform 116:10–17
25. R:A Language and Environment for Statistical Computing. R Foun- dation for Statistical Computing, 2018. Vienna, Austria
26. Matsuoka H, Masaki T, Sugiyama M et al (2007) Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma. Langenbecks Arch Surg 392:543–547
27. Ogura A, Konishi T, Beets GL et al (2019) Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 154:e192172
28. Hoshino N, Murakami K, Hida K et al (2019) Diagnostic accuracy of magnetic resonance imaging and computed tomography for lat- eral lymph node metastasis in rectal cancer: a systematic review and meta-analysis. Int J Clin Oncol 24:46–52
29. Yang X, Yang S, Hu T et al (2020) What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review. Cancer Med 9:4477–4489
30. Ma P, Yuan Y, Yan P et al (2020) The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: a systematic review and meta-analysis. Asian J Surg 43:891–901
31. Couwenberg AM, Burbach JPM, van Grevenstein WMU et al (2018) Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis. Clin Colorectal Cancer 17:e499–e512